Tropicamide
Tropicamide

16.32
Promotes controlled pupil dilation to grant specialists an unobstructed view of the retina for Eye Care by paralyzing the sphincter muscle of the iris to force the eye open wide.


Ingredient
Category
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Tropicamide
Reference Brand
Tropicamide
Product Origin
Generic Product
Reference Manufacturer
Alcon
Product Form
Eye drops
Regulatory Classification
Rx
Primary Category
Eye Care
Product Category
Mydriatic
Pharmacological Class
Anticholinergic
Clinical Indications
Eye examination
Manufacturer Description
Tropicamide is designed to support ophthalmic examinations by dilating the pupils, allowing professionals to view the back of the eye clearly.
Mechanism of Action
Tropicamide acts as an anticholinergic agent that blocks the muscarinic receptors in the iris sphincter and the ciliary muscle. This causes the iris to relax, resulting in pupil dilation and temporary paralysis of the eye's focusing ability.
Route of Administration
Ocular
Onset Time
15–30 minutes
Duration
4–6 hours
Contraindications
Narrow-angle glaucoma
Severe Adverse Events
Increased eye pressure, dizziness
Common Side Effects
Blurred vision, stinging
Uncommon Side Effects
Light sensitivity, dry mouth
Pregnancy Safety Warnings
Use with caution.
Storage Guidelines
Protect from light; store in a cool place.
Related Products
Cyclopentolate, Atropine

Tropicamide FAQ

How do digital health platforms facilitate evaluation and access to Tropicamide in Singapore?

Digital health platforms support the distribution of diagnostic agents by verifying clinical requirements and facilitating connections with authorized providers who manage the assessment process for residents in Singapore.

Why are there cost variations between multi-source generic Tropicamide formulations and originator brands?

Formulation economics driven by manufacturing efficiencies and the overhead associated with establishing original research compounds contribute to the differences between generic Tropicamide and originator branded equivalents.

How can patients in Singapore verify the regulatory compliance and sourcing standards of digital health directories?

Patients can verify compliance by checking for alignment with the Health Sciences Authority standards and confirming the directory sourcing protocols through transparent disclosure of distributor partnerships.

What are the logistical or regulatory considerations when utilizing cross-border facilitation for Tropicamide?

Importing ocular reagents involves strict adherence to Health Sciences Authority personal import limits and the requirement for clinical documentation that supports the necessity of the specific diagnostic compound.

How does generic Tropicamide compare to originator formulas regarding clinical bioequivalence?

Generic Tropicamide provides identical active functionality to the originator product, as it must demonstrate strict bioequivalence to ensure the same diagnostic performance during eye examinations.

What is Tropicamide?

Ophthalmic investigations often utilize Tropicamide as a short-acting anticholinergic agent. Belonging to a group of compounds that inhibit muscarinic receptors, this substance functions primarily to interrupt nerve-muscle signaling in ocular structures. Eye care practitioners apply the solution to facilitate the temporary widening of the pupil and the relaxation of internal focusing mechanisms.

Diagnostic accuracy depends on the temporary suspension of autonomic functions within the iris sphincter muscle. Administering this agent allows clinical observation of the structures located within the posterior segment of the eye. Practitioners frequently utilize this method during routine vision examinations to inspect the retina and optic nerve head effectively.

Regulatory & Classification Profile

Regulatory frameworks categorize Tropicamide as a Pharmacy-Only Medicine within Singapore. Compliance with local healthcare standards requires professional oversight during the application of such ocular diagnostic reagents. Distribution of this compound adheres to the guidelines established by the Health Sciences Authority of Singapore to ensure the maintenance of safety and clinical standards.

Formulations & Associated Medications

Tropicamide exists as a bioequivalent generic formulation containing the active ingredient Tropicamide. Available formulations accessible through our website include Tropicamide bottle in strengths of 1%. These formulations serve as standard tools in ophthalmic practice, providing consistent active agent concentrations aligned with established diagnostic protocols.

Therapeutic Applications

Clinical use of Tropicamide focuses on specific applications within the field of optometry and ophthalmology:

  • Facilitating detailed fundus examinations for comprehensive ocular health assessment.
  • Supporting refraction procedures in patients requiring the temporary accommodation of visual focus.
  • Assisting in the management of specific inflammatory conditions affecting the anterior ocular segment.
  • Providing visual access to the peripheral retina for thorough structural evaluations.

Biological Action

Tropicamide operates by temporarily blocking the chemical messengers that trigger muscle contraction within the eye. Application leads to a brief widening of the pupil, known as mydriasis, and prevents the lens from shifting focus for distance or near viewing. Effects typically manifest rapidly following application to the ocular surface and dissipate as the agent clears from the system naturally.

Treatment Landscape & Drug Class

Tropicamide represents a standard anticholinergic class of diagnostic agents. Modern protocols utilize this class of compounds to gain temporary control over pupillary diameter and accommodative reflexes. Standard practice prioritizes these agents for their predictable duration of action and reliable diagnostic utility in both clinical and surgical environments.

Understanding the Safety Profile

Physiological responses to Tropicamide predominantly affect the local autonomic nervous system within the ocular tissues. Systemic absorption remains minimal when applying standard clinical volumes, though individual sensitivity can vary based on underlying personal health status. Ocular surface comfort and light sensitivity represent transient occurrences during the period of effect. Refer to the clinical data tables provided for specific contraindications, interactions, and potential reactions.

Clinical Disclosure

Tropicamide functions as a diagnostic tool designed for professional eye care settings. Medicines like Tropicamide differ in strength based on formulation, and users must acknowledge that the information provided serves as an educational overview rather than individual advice. We hold no clinical liability for the misuse of these materials. Always consult labeling and a healthcare professional to ensure the product aligns with specific vision requirements and personal health conditions before use.

Clinical Glossary

Mydriasis
The clinical term for the dilation of the pupil, often induced by medical agents for eye examinations.
Cycloplegia
The temporary paralysis of the ciliary muscle which prevents the eye from adjusting focus.
Anticholinergic
A class of substances that inhibit the action of acetylcholine to modulate muscle movement or glandular secretions.
Bioequivalence
A regulatory quality indicating that a generic product acts in the same manner as the original originator brand.
Information associated with Tropicamide is curated and periodically reviewed using established medical references and prescribing guidelines. Content is intended for general awareness and should be verified with a licensed healthcare professional before use.
Categories